iCAD(ICAD) - 2024 Q2 - Quarterly Results

iCAD Reports Financial Results for Second Quarter Ended June 30, 2024 NASHUA, N.H. – August 13, 2024 – iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and six months ended June 30, 2024. Second Quarter 2024 Highlights (Year over Year Performance): ● Total ARR was $9.2 million, up 7% ● Total revenues were ...